Optimizing cyclosporine therapy: dose, levels, and monitoring.

  • Paul Keown
  • Published 1988 in Transplantation proceedings


The use of CsA has evolved considerably in concept and practice since the First International Congress on this drug in 1983. CsA is now increasingly used as a component of a multiagent protocol, rather than as a single, potent agent, with adjunctive therapy selected to optimize induction or maintenance immunosuppression. Novel clinical developments include… (More)


Cite this paper

@article{Keown1988OptimizingCT, title={Optimizing cyclosporine therapy: dose, levels, and monitoring.}, author={Paul Keown}, journal={Transplantation proceedings}, year={1988}, volume={20 2 Suppl 2}, pages={382-9} }